Vider-Shalit T - Search Results

1

Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development.

Kovjazin R, Volovitz I, Daon Y, Vider-Shalit T, Azran R, Tsaban L, Carmon L, Louzoun Y. Kovjazin R, et al. Among authors: vider shalit t. Mol Immunol. 2011 Apr;48(8):1009-18. doi: 10.1016/j.molimm.2011.01.006. Epub 2011 Feb 12. Mol Immunol. 2011. PMID: 21316766 Free PMC article.

2

Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.

Vider-Shalit T, Raffaeli S, Louzoun Y. Vider-Shalit T, et al. Mol Immunol. 2007 Feb;44(6):1253-61. doi: 10.1016/j.molimm.2006.06.003. Epub 2006 Aug 22. Mol Immunol. 2007. PMID: 16930710

3

Human self-protein CD8+ T-cell epitopes are both positively and negatively selected.

Almani M, Raffaeli S, Vider-Shalit T, Tsaban L, Fishbain V, Louzoun Y. Almani M, et al. Among authors: vider shalit t. Eur J Immunol. 2009 Apr;39(4):1056-65. doi: 10.1002/eji.200838353. Eur J Immunol. 2009. PMID: 19291702 Free PMC article.

4

Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis.

Vider-Shalit T, Sarid R, Maman K, Tsaban L, Levi R, Louzoun Y. Vider-Shalit T, et al. Bioinformatics. 2009 Jun 15;25(12):i39-44. doi: 10.1093/bioinformatics/btp221. Bioinformatics. 2009. PMID: 19478014 Free PMC article.

5

MHC-I prediction using a combination of T cell epitopes and MHC-I binding peptides.

Vider-Shalit T, Louzoun Y. Vider-Shalit T, et al. J Immunol Methods. 2011 Nov 30;374(1-2):43-6. doi: 10.1016/j.jim.2010.09.037. Epub 2010 Oct 12. J Immunol Methods. 2011. PMID: 20920507 Free PMC article.

6

Precise score for the prediction of peptides cleaved by the proteasome.

Ginodi I, Vider-Shalit T, Tsaban L, Louzoun Y. Ginodi I, et al. Among authors: vider shalit t. Bioinformatics. 2008 Feb 15;24(4):477-83. doi: 10.1093/bioinformatics/btm616. Epub 2008 Jan 23. Bioinformatics. 2008. PMID: 18216070

7

The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire.

Vider-Shalit T, Almani M, Sarid R, Louzoun Y. Vider-Shalit T, et al. AIDS. 2009 Jul 17;23(11):1311-8. doi: 10.1097/QAD.0b013e32832c492a. AIDS. 2009. PMID: 19550286 Review.

8

Optimal viral immune surveillance evasion strategies.

Agranovich A, Vider-Shalit T, Louzoun Y. Agranovich A, et al. Among authors: vider shalit t. Theor Popul Biol. 2011 Dec;80(4):233-43. doi: 10.1016/j.tpb.2011.08.005. Epub 2011 Sep 2. Theor Popul Biol. 2011. PMID: 21925527 Free PMC article.

9

Phase-dependent immune evasion of herpesviruses.

Vider-Shalit T, Fishbain V, Raffaeli S, Louzoun Y. Vider-Shalit T, et al. J Virol. 2007 Sep;81(17):9536-45. doi: 10.1128/JVI.02636-06. Epub 2007 Jul 3. J Virol. 2007. PMID: 17609281 Free PMC article.

10

A systems immunology approach to the host-tumor interaction: large-scale patterns of natural autoantibodies distinguish healthy and tumor-bearing mice.

Merbl Y, Itzchak R, Vider-Shalit T, Louzoun Y, Quintana FJ, Vadai E, Eisenbach L, Cohen IR. Merbl Y, et al. Among authors: vider shalit t. PLoS One. 2009 Jun 25;4(6):e6053. doi: 10.1371/journal.pone.0006053. PLoS One. 2009. PMID: 19557135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters